Research Solutions Reports Fourth Quarter and Fiscal Year 2026 Results

Research Solutions reported FY2026 net income of $2.8M, up 123% year over year, and record adjusted EBITDA of $5.8M, up 10.6%, despite total revenue declining 1.5% to $48.3M. ARR increased 7.8% to $22.5M, led by 14.1% B2B ARR growth to $16.2M and $0.8M of AI-related ARR, while gross margin expanded 260bps to 51.9%. Q4 revenue fell 2.9% to $12.1M and adjusted EBITDA declined 11.4% to $1.4M as transaction revenue dropped 6.7%, partially offset by higher-margin platform growth and AI product investments.

Analysis

RSSS is becoming a higher-quality recurring-revenue asset, but the investable question is whether it can replace a shrinking, low-margin transaction stream quickly enough to restore consolidated top-line growth. Platform gross profit economics imply that each incremental $1 of subscription revenue contributes roughly $0.88 before opex, versus roughly $0.25 for transactions; consequently, modest B2B expansion can drive disproportionate EBITDA and valuation upside even while reported revenue remains flat. The near-term complication is that incremental B2B ARR and deployments decelerated in the latest quarter, so investors should not annualize the AI pipeline commentary until booked ARR, retention and sales-cycle data validate it.

The market may reward the margin mix shift over the next 1-3 months, but the balance sheet limits a premium SaaS multiple: cash is only modestly above the current contingent-consideration obligation, while the earnout’s accreted interest is a recurring drag until settled. AI-related ARR is presently too small to support a standalone AI valuation; the more credible upside case is that integrations lower customer-acquisition friction and raise enterprise seat expansion/ASP over 6-18 months. The contrarian downside is that large-model vendors and incumbent content/workflow providers can commoditize discovery interfaces, leaving RSSS dependent on publisher-access economics rather than differentiated AI.

A thesis break would be another quarter of declining platform net new ARR or an acceleration in transaction-volume deterioration without offsetting gross-profit growth. Conversely, evidence that AI products produce larger enterprise contracts, faster deployment growth, or B2B ARR reacceleration would support multiple expansion despite weak consolidated revenue.

Key Decisions for Investors

• Maintain RSSS on a watchlist rather than initiate before the call; require disclosure of FY27 ARR/growth expectations, AI pipeline conversion timing, net retention and earnout-settlement funding. Micro-cap liquidity and absent formal guidance make a pre-call position unattractive.
• If management establishes a credible path to reaccelerating B2B ARR above 15% and preserving positive operating cash flow, initiate a small 6-12 month long RSSS position. Underwrite upside to recurring gross-profit growth rather than an AI narrative; cap sizing given execution and liquidity risk.
• Use the next quarterly report as a catalyst checkpoint: add only if platform ARR growth reaccelerates and transaction declines no longer offset platform revenue; exit if platform net new ARR remains below the recent quarterly run rate or adjusted EBITDA falls despite gross-margin expansion.
• Avoid treating cash as fully deployable for acquisitions or buybacks until the approximately $7.3 million current earnout obligation is resolved; an M&A announcement before that resolution would increase financing/dilution risk rather than constitute a standalone bullish catalyst.